A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/11/2011	CA2390472C Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
10/11/2011	CA2362658C In vitro production of transplantable cartilage tissue
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/11/2011	CA2336743C Antigenic peptides derived from telomerase
10/11/2011	CA2325442C Treatment of cardiac hypertrophy using interferon-gamma
10/11/2011	CA2248937C Peptide-based immunotherapeutic agent for treating allergic diseases
10/06/2011	WO2011123858A2 Ccn3 peptides and analogs thereof for therapeutic use
10/06/2011	WO2011123842A2 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
10/06/2011	WO2011123830A2 Alpha 1-antitrypsin compositions and methods of making and using same
10/06/2011	WO2011123826A2 Prevention and treatment of cast nephropathy
10/06/2011	WO2011123683A2 Protease activated cytokines
10/06/2011	WO2011123652A1 Rfamide-related peptides and methods thereof
10/06/2011	WO2011123456A1 Botulinum toxin dosage regimen for chronic migraine prophylaxis
10/06/2011	WO2011123396A1 Compositions and methods for the removal of biofilms
10/06/2011	WO2011123179A2 Alkylated sp-c peptoid compounds and related surfactant compositions
10/06/2011	WO2011123061A1 Amphiphilic linear peptide/peptoid and hydrogel comprising the same
10/06/2011	WO2011123041A1 Fertilization prediction and promotion
10/06/2011	WO2011123013A1 Method for diagnosing and creating immunogenic tolerance in contact allergy and other epithelial immunotoxicological ailments
10/06/2011	WO2011122944A1 Pea protein peptides with anti helicobacter pylori activity
10/06/2011	WO2011122937A1 Pea protein peptides with anti helicobacter pylori activity
10/06/2011	WO2011122923A2 Long-acting interferon beta formulation using immunoglobulin fragment
10/06/2011	WO2011122921A2 An insulin conjugate using an immunoglobulin fragment
10/06/2011	WO2011122916A2 Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of tip41 which is a trail sensitizer target gene
10/06/2011	WO2011122647A1 Hemoglobin material intermediate product used in artificial oxygen carrier manufacturing
10/06/2011	WO2011122601A1 Intervertebral disc nucleus pulposus stem/progenitor cell, method for culturing same, and application
10/06/2011	WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof
10/06/2011	WO2011121496A1 Composition comprising insulin and herbal oil for transdermal or transmucosal administration
10/06/2011	WO2011121289A2 Compounds and their use
10/06/2011	WO2011121123A1 Factor xii inhibitors for treating interstitial lung disease
10/06/2011	WO2011121036A2 Induction of arteriogenesis using specific factors or by cell therapy with polarized myeloid cells
10/06/2011	WO2011120902A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and tumor initiating cells
10/06/2011	WO2011120608A1 Implant cannula having an implant and method for securing implants in an injection cannula
10/06/2011	WO2011120474A1 Method for inhibiting hiv replication in mammal and human cells
10/06/2011	WO2011120359A1 Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof
10/06/2011	WO2011120076A1 Prevention and treatment of cutaneous lupus erythematosus
10/06/2011	WO2011120071A1 Oxytocin peptide analogues
10/06/2011	WO2011100055A3 Methods for preventing or treating viral infection
10/06/2011	WO2011098262A3 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
10/06/2011	WO2011097596A3 Methods of using agents that modulate claudin expression
10/06/2011	WO2011094806A8 Diagnostic and prognostic assay for breast cancer
10/06/2011	WO2011093710A8 Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions
10/06/2011	WO2011072138A9 Therapeutic use of protein-polymer conjugates
10/06/2011	WO2011069042A3 Nutritional formulation comprising a cow's milk peptide-containing hydrolysate and/or peptides derived thereof for tolerance induction
10/06/2011	WO2011066970A3 Transdermal therapeutic system for the administration of peptides
10/06/2011	WO2011066260A3 Formulations comprising aminosterols
10/06/2011	WO2011063989A3 Treatment of nerve injuries
10/06/2011	WO2011060268A3 Diagnosis and treatment of cancer using histone deacetylase inhibitors and radiolabeled metaiodobenzylguanidine
10/06/2011	WO2011058508A3 Compositions for the treatment of chemoresistant leukaemia and/or of potentially chemoresistant leukaemia
10/06/2011	WO2011057251A3 Treatment of heart disease
10/06/2011	WO2011053822A3 Notch inhibition in the treatment and prevention of obesity and metabolic syndrome
10/06/2011	WO2011050357A3 Protein arginine deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer
10/06/2011	WO2011036443A3 Si protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders
10/06/2011	WO2011034583A3 Inhibition of endosomal toll-like receptor activation
10/06/2011	WO2011006088A3 Fluorine containing compounds and methods of use thereof
10/06/2011	WO2010089554A8 Grass peptides for vaccine
10/06/2011	WO2010008561A3 Methods and compositions for protecting against cytotoxic therapy
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110246081 Metabolomics-Based Identification of Disease-Causing Agents
10/06/2011	US20110245867 Haemostatic Kit, A Method of Preparing A Haemostatic Agent and a Method of Promoting Haemostatis
10/06/2011	US20110245798 Method of Treating Parkinson's Disease in Humans by Convection-Enhanced Infusion of Glial Cell-Line Derived Neurotrophic Factor to the Putamen
10/06/2011	US20110245772 Focal calcium channel modulation
10/06/2011	US20110245471 NUCLEAR FACTOR kappaB INDUCING FACTOR
10/06/2011	US20110245459 Processes for Intermediates for Macrocyclic Compounds
10/06/2011	US20110245330 P185neu-encoding dna and therapeutical uses thereof
10/06/2011	US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011	US20110245189 Composition and method for the treatment of eye disease
10/06/2011	US20110245188 Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
10/06/2011	US20110245187 Mesenchymal cell proliferation promoter and skeletal system biomaterial
10/06/2011	US20110245186 Recombinant e-selectin made in insect cells
10/06/2011	US20110245185 APO-2 ligand/trail formulations
10/06/2011	US20110245184 Treatment of surgical adhesions
10/06/2011	US20110245181 Compositions and Methods for Skin Treatment
10/06/2011	US20110245180 Modified Peptide that reduces pain in peripheral neuropathy
10/06/2011	US20110245179 Composition for Prevention or Treatment of Heart Failure
10/06/2011	US20110245178 Exendin Fusion Proteins
10/06/2011	US20110245177 Method for topical treatment of eye disease and composition and device for said treatment
10/06/2011	US20110245176 Novel peptides that bind to the erythropoietin receptor
10/06/2011	US20110245175 INHIBITING INTERACTION BETWEEN THE HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED
10/06/2011	US20110245174 Glp-1 fusion polypeptides
10/06/2011	US20110245173 Long-Acting GLP-1 Derivatives, and Methods of Treating Cardiac Dysfunction
10/06/2011	US20110245172 Biocompatible oligomer-polymer compositions
10/06/2011	US20110245171 Rehydration compositions comprising epidermal growth factor (egf)
10/06/2011	US20110245170 Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
10/06/2011	US20110245169 Protection, restoration and enhancement of erythropoietin responsive cells, tissues and organs
10/06/2011	US20110245168 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/06/2011	US20110245167 NaK-ATPase-Derived Peptide SRC Inhibitors and Ouabain Antagonists and Uses Thereof
10/06/2011	US20110245166 Sugar chain added glp-1 peptide
10/06/2011	US20110245165 Peptide agonists of glp-1 activity
10/06/2011	US20110245164 Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor
10/06/2011	US20110245163 Stabilised Insulin Compositions
10/06/2011	US20110245162 Methods for treating diabetes and reducing body weight
10/06/2011	US20110245161 Use of Ghrelin Splice Variant for Treating Hypercholesterolemia and/or High Cholesterol and/or High Cholesterol Complication and/or Lipemia and/or Lipemia Complication and/or Coronary Heart Disease and/or Weight Management and/or Diabetes and/or Hyperglycemia
10/06/2011	US20110245160 Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity
10/06/2011	US20110245159 Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same
10/06/2011	US20110245158 High Protein Supplement
10/06/2011	US20110245156 Novel antiviral compounds, compositions, and methods of use
10/06/2011	US20110245155 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
10/06/2011	US20110245154 Methods and Compositions for Treating Viral or Virally-Induced Conditions
10/06/2011	US20110245153 Neutralizing Agents for Bacterial Toxins

1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 3163